Skip to main navigation Skip to search Skip to main content

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.

Translated title of the contribution: Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.
  • A.A. van Everdingen
  • , J.W.G. Jacobs
  • , D.R. Siewertsz van Reesema
  • , J.W.J. Bijlsma

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionLow-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.
Original languageUndefined/Unknown
Pages (from-to)1-12
Number of pages13
JournalAnnals of Internal Medicine
Volume136
Publication statusPublished - 2002

Cite this